###begin article-title 0
###xml 65 72 65 72 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">De Novo</italic>
Noncompaction of the Ventricular Myocardium Is Associated with a De Novo Mutation in the beta-Myosin Heavy Chain Gene
###end article-title 0
###begin p 1
Conceived and designed the experiments: RG BB PN TS SW WB PB. Performed the experiments: BB SW KR MM EK SH WB CS JB AD MW EM PB. Analyzed the data: RG BB PN TS SW KR MM WH EK SH WB CS JB AD MW EM PB. Contributed reagents/materials/analysis tools: BB SW WB PB. Wrote the paper: RG BB PN TS SW HV WH WB PB.
###end p 1
###begin p 2
###xml 688 692 688 692 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYH6</italic>
###xml 697 701 697 701 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYH7</italic>
###xml 836 843 829 836 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">de novo</italic>
###xml 885 889 878 882 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYH7</italic>
###xml 979 988 972 981 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In silico</italic>
Noncompaction of the ventricular myocardium (NVM) is the morphological hallmark of a rare familial or sporadic unclassified heart disease of heterogeneous origin. NVM results presumably from a congenital developmental error and has been traced back to single point mutations in various genes. The objective of this study was to determine the underlying genetic defect in a large German family suffering from NVM. Twenty four family members were clinically assessed using advanced imaging techniques. For molecular characterization, a genome-wide linkage analysis was undertaken and the disease locus was mapped to chromosome 14ptel-14q12. Subsequently, two genes of the disease interval, MYH6 and MYH7 (encoding the alpha- and beta-myosin heavy chain, respectively) were sequenced, leading to the identification of a previously unknown de novo missense mutation, c.842G>C, in the gene MYH7. The mutation affects a highly conserved amino acid in the myosin subfragment-1 (R281T). In silico simulations suggest that the mutation R281T prevents the formation of a salt bridge between residues R281 and D325, thereby destabilizing the myosin head. The mutation was exclusively present in morphologically affected family members. A few members of the family displayed NVM in combination with other heart defects, such as dislocation of the tricuspid valve (Ebstein's anomaly, EA) and atrial septal defect (ASD). A high degree of clinical variability was observed, ranging from the absence of symptoms in childhood to cardiac death in the third decade of life. The data presented in this report provide first evidence that a mutation in a sarcomeric protein can cause noncompaction of the ventricular myocardium.
###end p 2
###begin title 3
Introduction
###end title 3
###begin p 4
###xml 655 658 655 658 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001362-Richardson1">[1]</xref>
###xml 1081 1084 1065 1068 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001362-Maron1">[2]</xref>
Cardiomyopathies are diseases of the heart associated with cardiac dysfunction of variable severity and prognosis. They have in the past been classified mainly based on morphological, but also on functional criteria. The terms "hypertrophy" or "dilatation" of the ventricles were used early to distinguish the most frequent types of cardiomyopathy. "Restriction" of ventricular filling and "arrhythmogenesis" with progressive loss of myocardial tissue described, in functional terms, the less frequent classes of cardiomyopathies. A generally accepted scheme of classifying these disorders was published by a World Health Organization (WHO) panel in 1995 [1]. Developments since then regarding newly discovered causes and advanced discrimination of phenotypes have caused an expert panel in the US to propose an update of previous definitions by stating that these diseases constitute "a heterogeneous group of myocardial disorders associated with mechanical and/or electrical dysfunctionem leaderem leaderdue to a variety of causes that are frequently genetic" (for reference see [2]). These diseases have long been divided into "primary" and "secondary" cardiomyopathies. Primary cardiomyopathies (genetic or nongenetic) are predominantly confined to heart muscle. Secondary cardiomyopathies exhibit myocardial dysfunction in conjunction with a large variety of acquired or inherited systemic diseases. The case presented in this report belongs to the class of primary cardiomyopathies.
###end p 4
###begin p 5
###xml 828 831 827 830 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001362-Lind1">[3]</xref>
###xml 781 789 <span type="species:ncbi:9606">patients</span>
To briefly characterize the major members of this class, the most frequent disorder is "hypertrophic cardiomyopathy" (HCM [MIM 192600]) typically involving a hypertrophic, nondilated left ventricle often associated with left-ventricular outflow tract obstruction. Heart failure symptoms-with a relatively high risk of sudden cardiac death-develop usually in young adults or later in life. HCM has been traced to a variety of mutations in genes encoding contractile proteins of the cardiac sarcomere. Most commonly affected are the genes for ss-myosin heavy chain and for myosin-binding protein C. Nine other sarcomeric genes contribute less frequently to HCM. More than 250 different autosomal dominant mutations (probably many more, not all are published) have been identified in patients and families (for a recent review see [3]).
###end p 5
###begin p 6
###xml 941 944 941 944 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001362-Karkkainen1">[4]</xref>
###xml 907 915 <span type="species:ncbi:9606">children</span>
A typical feature of "dilated cardiomyopathy" (DCM [MIM 115200]) (with genetic or nongenetic causes) is ventricular chamber enlargement linked to systolic dysfunction. Clinical hallmarks are progressive heart failure due to a gradual loss of left-ventricular contractile function coupled with a high risk of sudden or heart failure-related death. Up to 35% of DCM cases have been reported as familial linked to more than 20 genomic loci and genes. The predominant mode of transmission is autosomal dominant. X-linked, autosomal recessive or mitochondrial inheritance are less frequent. Several mutated genes code for the same contractile proteins that otherwise cause HCM. Other genes encode Z-disc binding proteins, sarcolemmal and nuclear envelope components and transcriptional coactivators. Regarding genetic causes, overlap exists not only with HCM, but also with X-linked cardioskeletal myopathies in children (for a recent review see [4]).
###end p 6
###begin p 7
###xml 641 644 641 644 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001362-SenChowdhry1">[5]</xref>
"Arrhythmogenic right-ventricular cardiomyopathy/dysplasia" (ARVC/D [MIM 609040], a rare disorder) has a broad clinical spectrum usually presenting with ventricular tachyarrhythmia, syncopes, even cardiac arrest. This condition is often not easily diagnosed. A sensitive marker is a biopsy from the right ventricle exposing fibrofatty infiltrations with interspersed strands of myocytes. Inheritance is autosomal dominant in most cases. Four genes associated with ARVC/D have been detected involving intermediate filaments and desmosomes and the calcium release channel RyR2 in the myocardial sarcoplasmic reticulum (for a recent review see [5]).
###end p 7
###begin p 8
###xml 247 250 247 250 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001362-Engberding1">[6]</xref>
###xml 413 416 413 416 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001362-Chin1">[7]</xref>
###xml 417 420 417 420 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001362-Bleyl1">[9]</xref>
###xml 500 503 500 503 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001362-Bleyl1">[9]</xref>
###xml 686 689 686 689 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001362-Chin1">[7]</xref>
###xml 691 695 691 695 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001362-Ichida2">[10]</xref>
###xml 696 700 696 700 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001362-Murphy1">[12]</xref>
###xml 1018 1021 1018 1021 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001362-Chin1">[7]</xref>
###xml 1023 1027 1023 1027 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001362-Sedmera1">[13]</xref>
"Noncompaction of (left-) ventricular myocardium" (NVM, also designated LVNC [MIM 300183]), a recently recognized congenital cardiomyopathy, shows typically a "spongy" appearance of the left-ventricular myocardium. NVM was first described in 1984 [6]. Albeit rare, it is now due to improved diagnostic technology recognized more frequently than previously. Both, syndromic and isolated cases have been identified [7]-[9]. Clinical consequences are variable. Early onset of symptoms has been reported [9], but others described long latency with presentation in adults at an advanced age, generally including congestive heart failure, ventricular arrhythmias and systemic thromboembolism [7], [10]-[12]. The myocardium of affected individuals is characterized by persisting trabeculations and deep intertrabecular recesses, reminiscent of the cardiac muscle in the developing heart. Accordingly, noncompaction of the ventricular myocardium has been suggested to result from an intrauterine arrest of cardiac development [7], [13].
###end p 8
###begin p 9
###xml 124 127 124 127 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TAZ</italic>
###xml 230 233 230 233 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001362-Bleyl1">[9]</xref>
###xml 279 283 279 283 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LDB3</italic>
###xml 360 364 360 364 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DTNA</italic>
###xml 395 399 395 399 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001362-Ichida2">[10]</xref>
###xml 401 405 401 405 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LDB3</italic>
###xml 484 488 484 488 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001362-Vatta1">[14]</xref>
###xml 490 494 490 494 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DTNA</italic>
###xml 631 635 627 631 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001362-Pauli1">[15]</xref>
###xml 637 641 633 637 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001362-SasseKlaassen1">[16]</xref>
###xml 208 216 <span type="species:ncbi:9606">children</span>
In family studies evidence has been obtained for genetic heterogeneity of NVM. X-chromosomal causes have been linked to the TAZ gene encoding taffazin [MIM 300394], also associated with the Barth syndrome in children [MIM 302060] [9]. Autosomal mutations have been identified in LDB3, the LIM domain-binding protein 3 gene on chromosome 10 [MIM 605906] and in DTNA on chromosome 18 [MIM 601239] [10]. LDB3 encodes ZASP, the 'Z-band alternatively spliced PDZ motif-containing protein' [14]. DTNA encodes alpha-dystrobrevin. Other investigations pointed to additional NVM loci with unknown genes on chromosome 5 and 11, respectively [15], [16].
###end p 9
###begin p 10
###xml 390 394 390 394 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYH6</italic>
###xml 412 416 412 416 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYH7</italic>
###xml 596 600 586 590 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYH7</italic>
###xml 681 690 671 680 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in silico</italic>
Here we report on the results of a clinical and genetic analysis of a large German family suffering from NVM. The detailed clinical and morphologic characterization of the members of family DU-11 afforded the identification of a disease-related genomic locus on chromosome 14q by a genome-wide linkage analysis. Further refinement of the disease gene region led to sequencing of two genes, MYH6 [MIM 160710] and MYH7 [MIM 160760], encoding the alpha- and beta-myosin heavy chain, respectively. A previously unknown missense mutation was detected in the gene encoding the beta-myosin heavy chain (MYH7), the predominant myosin isoform in the ventricular myocardium. Finally, via an in silico analysis clues to structural and functional consequences of the mutation in the beta-myosin heavy chain were obtained.
###end p 10
###begin title 11
Results
###end title 11
###begin title 12
Clinical Findings
###end title 12
###begin p 13
###xml 207 213 207 213 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001362-g001">fig. 1</xref>
###xml 512 520 512 520 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001362-g002">figure 2</xref>
###xml 585 592 585 592 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0001362-t001">table 1</xref>
###xml 597 603 597 603 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001362-g003">fig. 3</xref>
###xml 784 805 784 805 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s4">Materials and Methods</xref>
###xml 571 579 <span type="species:ncbi:9606">patients</span>
###xml 638 645 <span type="species:ncbi:9606">patient</span>
###xml 731 736 <span type="species:ncbi:9606">child</span>
In order to identify all cases of noncompaction within the family DU-11, transthoracic echocardiography (TTE) was employed (2D mode, M mode and color Doppler imaging). NVM was observed in three generations (fig. 1). The morphological phenotype observed varied from apical thickening with mild trabecularization to a spongy myocardium affecting the apical half of the left ventricle. The sponge-like appearance of the apical myocardium with excessive trabeculations in apex regions of both ventricles is shown in figure 2. NVM was further confirmed by TTE in a total of 9 patients (see table 1 and fig. 3 for echocardiographs of the index patient and her sister's daughter). Two deceased individuals (II:3 and III:2) and one living child (IV:6) were considered partially affected (see Materials and Methods).
###end p 13
###begin title 14
###xml 77 81 77 81 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYH7</italic>
Pedigree of family DU-11 with haplotypes on chromosome 14 and segregation of MYH7 mutation R281T (c.842G>C).
###end title 14
###begin p 15
###xml 429 433 429 433 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYH7</italic>
###xml 206 213 <span type="species:ncbi:9606">patient</span>
Family members are shown by filled black symbols (affected), by half filled symbols (partially affected), open symbols (unaffected) and gray symbols (unknown affection status). An arrow points to the index patient. The disease associated haplotype is shown by filled black bars. Markers within the minimum disease associated haplotype are boxed. Below the haplotypes of each individual the occurrence of wild-type (+) and mutant MYH7 alleles (-) is indicated.
###end p 15
###begin title 16
###xml 18 25 <span type="species:ncbi:9606">patient</span>
Imaging of NVM in patient III:8 of family DU-11.
###end title 16
###begin p 17
A, Magnetic resonance image: long-axis plane in diastole. Prominent myocardial trabeculations and deep intertrabecular recesses are seen in the apical half of the right and left ventricle as indicated by arrows. B, Magnetic resonance image: short-axis plane in diastole. In the apex region the cavum and the myocardial wall can not clearly be distinguished. Extensive trabeculations in this region produce a sponge-like appearance of the myocardium. C, Two-dimensional echocardiograph: apical four-chamber view in diastole with (right) and without (left) color flow imaging. A massive apical thickening is seen without any evidence of trabeculations in the left image. In contrast, color flow imaging (right image) shows more clearly the recesses extending deeply into the myocardial wall. D, Two-dimensional echocardiograph: parasternal short-axis view in diastole with (right) and without (left) color flow imaging. The left image shows a mesh-like morphology in the mid-region of the left ventricle. The cavum is not clearly discernable. The right image demonstrates numerous small blood-flow eddies within the sponge-like myocardium (as shown by color flow imaging). LV, left ventricle; RV, right ventricle; LA, left atrium; RA, right atrium.
###end p 17
###begin title 18
###xml 28 35 <span type="species:ncbi:9606">patient</span>
Imaging of NVM in the index patient (III:4, panel A) and her sister's daughter (IV:13, panel B).
###end title 18
###begin p 19
Shown are two-dimensional echocardiographs (ventricular part of a four-chamber view) in diastole, with (right) and without (left) color flow imaging. Arrows point to recesses in the myocardial wall.
###end p 19
###begin title 20
###xml 0 7 <span type="species:ncbi:9606">Patient</span>
Patient Characteristics (initial presentation)
###end title 20
###begin p 21
Age at presentation in years; dc, deceased;
###end p 21
###begin p 22
HF, chronic heart failure; NYHA, classi-fication of heart failure according to the New York Heart Association; CD, cardiac death
###end p 22
###begin p 23
EA, Ebstein's anomaly;
###end p 23
###begin p 24
ASD, atrial septal defect;
###end p 24
###begin p 25
aECG, abnormal ECG;
###end p 25
###begin p 26
###xml 93 113 93 113 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s4">Material and Methods</xref>
###xml 233 237 233 237 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYH7</italic>
NVM, non-compaction of the ventricular myocardium; +, affected; (+), partially affected; see Material and Methods for details on the affection status; non-isolated/isolated: with/without EA and/or ASD. Listed are all carriers of the MYH7 mutation and in addition individual III-2 who was not genotyped.
###end p 26
###begin p 27
###xml 137 144 <span type="species:ncbi:9606">patient</span>
###xml 169 176 <span type="species:ncbi:9606">patient</span>
In addition to NVM, three individuals displayed an atrial septal defect (ASD [MIM 108800]) and Ebstein's anomaly (EA, [MIM 224700]). One patient had NVM and ASD and one patient showed NVM in combination with EA. All probands showed normal thickness of the interventricular septum and of the free ventricular wall. Signs of a canonical hypertrophic cardiomyopathy, such as asymmetric hypertrophy or thickening of the interventricular septum, were not observed.
###end p 27
###begin p 28
NVM in family DU-11 was generally associated with a hypokinetic apex (as opposed to the hyperkinetic apex associated with apical HCM). As a consequence, the pump function was reduced (see below). In contrast to the typical picture of dilated cardiomyopathy, the end-diastolic diameter was below 55 mm in all adult probands.
###end p 28
###begin p 29
###xml 10 17 <span type="species:ncbi:9606">patient</span>
###xml 447 454 <span type="species:ncbi:9606">patient</span>
###xml 511 518 <span type="species:ncbi:9606">Patient</span>
###xml 964 970 <span type="species:ncbi:9606">infant</span>
###xml 1026 1029 <span type="species:ncbi:9606">man</span>
###xml 1062 1069 <span type="species:ncbi:9606">Patient</span>
The index patient (III:4) presented at the age of 39 years with dyspnoea upon exertion. Her condition and the condition of her sister (III:8) deteriorated within 3 years after initial presentation, resulting in a severely reduced pump function (2.4 and 2.1 l/min, respectively , measured using thermodilution; normal range: 4.0-10.2 l/min). They are currently enlisted for heart transplantation. Cardiac symptoms were also reported from the index patient's mother (II:3) and from her sister's daughter (IV:13). Patient II:3 suffered from an atrio-ventricular block (AV-block) which required implantation of a pacemaker. She died from sepsis related to a pacemaker-associated infection. The clinical status of individual IV:13 changed from asymptomatic to NYHA I (classification of heart failure according to the New York Heart Association) during follow-up. Two cases of premature death were reported from the third generation. One member of the family died as an infant from unknown cause (III:1), and another one as a young man at the age of 26 years (III:2). Patient III:2 suffered from a hemodynamically relevant defect of the atrial septum, recurrent syncopes and cardiac death. Eight family members were clinically asymptomatic at presentation, but had clear morphological signs of noncompaction. Regarding clinical severity, there is a tendency of NVM to develop unfavorably in adult family members. Based on the variable and age-dependent clinical expressivity we considered a reduced penetrance of the phenotype for further genetic analysis.
###end p 29
###begin title 30
Linkage of NVM to chromosome 14q
###end title 30
###begin p 31
###xml 87 90 87 90 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001362-Bleyl1">[9]</xref>
###xml 92 96 92 96 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001362-Ichida2">[10]</xref>
###xml 98 102 98 102 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001362-Vatta1">[14]</xref>
###xml 103 107 103 107 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001362-SasseKlaassen1">[16]</xref>
###xml 867 874 863 870 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D14S990</italic>
###xml 887 894 881 888 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001362-g004">fig. 4A</xref>
###xml 1056 1063 1050 1057 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D14S990</italic>
###xml 1335 1342 1327 1334 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D14S264</italic>
###xml 1344 1350 1336 1342 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001362-g001">fig. 1</xref>
###xml 1355 1362 1347 1354 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001362-g004">fig. 4B</xref>
###xml 1579 1586 1571 1578 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">de novo</italic>
###xml 1801 1808 1793 1800 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D14S990</italic>
###xml 1884 1888 1876 1880 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYH6</italic>
###xml 1892 1896 1884 1888 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYH7</italic>
###xml 1295 1303 <span type="species:ncbi:9606">patients</span>
###xml 1680 1688 <span type="species:ncbi:9606">children</span>
In previous family studies, evidence has been obtained for genetic heterogeneity of NVM[9], [10], [14]-[16]. Two of the proteins involved, ZASP and alpha-dystrobrevin, are linked to the myocardial cytoskeleton. To identify the locus underlying NVM in family DU-11, we performed a genome-wide linkage analysis using microsatellite markers at a spacing of about 10 cM. We used morphological changes as determined by echocardiography to define a total of 9 affected, 2 partially affected and 13 unaffected family members, which we all included into the genome scan, and found significant linkage to a locus on chromosome 14. Under the assumption of a dominant mode of inheritance with a reduced penetrance of 90% for the affected individuals and of 50% for the partially affected individuals (II:3 and IV:6) a maximum two point LOD score of 4.15 was obtained for marker D14S990 at phi = 0 (fig. 4A). Calculations under the same assumptions but with a penetrance of either 80% or 70% resulted in slightly reduced maximum LOD scores of 3.82 and 3.53 for marker D14S990 at phi = 0, respectively (data not shown). We saturated the critical region on chromosome 14 with additional markers and constructed haplotypes. Obligate recombinants revealed a minimum common disease haplotype, i.e. shared by all patients, ranging from 14ptel to marker D14S264 (fig. 1 and fig. 4B). The finding that proband II:3 was clinically affected, while the two sisters who shared the same haplotype (probands II:1 and II:2) were not, allowed to tentatively conclude that individual II:3 was a carrier of a de novo mutation. In this context it is worth to note that neither of the two unaffected sisters had children which could have been analyzed for the presence or absence of NVM. A LOD score of 3.82 (or 3.53) for the marker D14S990 led us to suppose a mutation in either of the two myosin heavy chain genes MYH6 or MYH7, both mapping to this region of chromosome 14. To test this suggestion, the two genes coding for alpha- and beta-myosin heavy chain were subsequently sequenced.
###end p 31
###begin title 32
Genetic analysis.
###end title 32
###begin p 33
###xml 402 409 402 409 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D14S264</italic>
###xml 439 443 439 443 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYH7</italic>
###xml 638 641 638 641 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYO</italic>
###xml 659 664 659 664 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYOII</italic>
###xml 778 785 <span type="species:ncbi:9606">patient</span>
A, Linkage analysis. Two-point LOD scores for all chromosomes under the assumption of a reduced penetrance of 90% are shown. In the line below the diagram each red slash indicates the position of an analyzed marker on the corresponding chromosome. B, Genetic map of the candidate region 14cen-14q12. A part of the deCODE map is shown in the upper part. The critical interval is delimited by 14ptel and D14S264. The genomic organization of MYH7 is delineated in the lower part. Exons are indicated by filled boxes and introns by horizontal lines. The translational start codon is located in exon 3. The positions of the intragenic markers MYO I in intron 1and MYOII in intron 24 are shown. The mutation was identified in exon 10. C, Mutation analysis. Chromatograms of the index patient III:4 and her unaffected son IV:2 are shown. The mutation site is marked by an arrow. Parts of the nucleotide sequence (from c.835 to c.849) and protein sequence (from 279 to 283) are given below.
###end p 33
###begin title 34
###xml 23 27 23 27 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYH7</italic>
A missense mutation in MYH7 cosegregates with NVM
###end title 34
###begin p 35
###xml 47 51 47 51 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYH6</italic>
###xml 56 60 56 60 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYH7</italic>
###xml 223 227 206 210 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001362-Reiser1">[17]</xref>
###xml 229 233 212 216 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001362-Kurabayashi1">[18]</xref>
###xml 271 275 254 258 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYH7</italic>
###xml 334 338 317 321 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYH7</italic>
###xml 585 592 565 572 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001362-g004">fig. 4C</xref>
###xml 1154 1161 1134 1141 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">de novo</italic>
###xml 1417 1421 1397 1401 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYH7</italic>
###xml 1485 1489 1465 1469 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LDB3</italic>
###xml 1517 1521 1497 1501 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DTNA</italic>
###xml 1692 1696 1668 1672 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYH6</italic>
###xml 1882 1886 1854 1858 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYH7</italic>
###xml 207 212 <span type="species:ncbi:9606">human</span>
###xml 352 359 <span type="species:ncbi:9606">patient</span>
###xml 1174 1181 <span type="species:ncbi:9606">patient</span>
The defined critical region includes the genes MYH6 and MYH7 encoding the cardiac alpha- and beta-myosin heavy chains (MHC-alpha and MHC-beta), respectively. Since MHC-beta is the predominant isoform in the human ventricle [17], [18], we decided to investigate in detail MYH7 as a likely candidate gene. By sequencing the 40 exons of MYH7 in the index patient a heterozygous single nucleotide exchange at the position c.842G>C in exon 10 was identified. As a consequence, a positively charged arginine is replaced by an uncharged threonine residue at position 281 of MHC-beta (R281T) (fig. 4C). As found by pyrosequencing and restriction fragment length polymorphism analysis, this substitution is present in all family members affected by NVM but absent from all unaffected family members. Thus, a perfect cosegregation between the NVM phenotype (affected and partially affected) and the R281T mutation was observed in our family. The absence of both the mutation and noncompaction in two siblings who carry the same "disease" haplotype as their affected sister (II:3) may be explained by a germ line mutation in one of the parents. The occurrence of a de novo mutation in patient II:3 would provide a further strong argument in favor of the disease-causing nature of this mutation. To exclude a neutral polymorphic variant, 184 healthy control individuals were tested negative for the exchange at position c.842 of MYH7. Further, it is unlikely that two other disease-causing genes, LDB3 (encoding Cypher/ZASP) and DTNA (encoding alpha-dystrobrevin), contribute to noncompaction observed in family DU-11 since no linkage was found with either of these loci. Finally, sequencing of the gene MYH6 did not reveal any missense or truncation mutation in the alpha-myosin heavy chain gene (data not shown). In a nutshell, we have detected a new, hitherto unknown mutation in exon 10 of MYH7, responsible for a phenotype previously not linked to this gene.
###end p 35
###begin title 36
Assumed consequences of the R281T mutation
###end title 36
###begin p 37
###xml 243 250 240 247 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001362-g005">fig. 5A</xref>
###xml 314 318 311 315 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001362-Rayment1">[19]</xref>
###xml 470 474 464 468 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001362-Rayment1">[19]</xref>
###xml 570 585 564 579 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D. melanogaster</italic>
###xml 617 623 611 617 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001362-g006">fig. 6</xref>
###xml 894 898 882 886 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001362-Rayment1">[19]</xref>
###xml 1077 1084 1065 1072 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001362-g005">fig. 5B</xref>
###xml 570 585 <span type="species:ncbi:7227">D. melanogaster</span>
###xml 609 615 <span type="species:ncbi:9606">humans</span>
###xml 754 759 <span type="species:ncbi:9606">human</span>
###xml 792 799 <span type="species:ncbi:9031">chicken</span>
###xml 879 884 <span type="species:ncbi:9606">human</span>
###xml 949 954 <span type="species:ncbi:9606">human</span>
###xml 961 968 <span type="species:ncbi:9031">chicken</span>
###xml 1051 1056 <span type="species:ncbi:9606">human</span>
###xml 1062 1069 <span type="species:ncbi:9031">chicken</span>
beta-myosin is one of the principal constituents of the contractile apparatus of ventricular myocytes. It consists of two heavy chains and two pairs of light chains. The subfragment-1 (S1) contains the ATPase site and an actin binding region (fig. 5A), both are crucial for the movement of actin relative to myosin[19]. The R281T missense mutation is located in the globular head of MHC-beta and affects a position in the vicinity of the switch I loop of the ATPase site[19]. R281 is highly conserved in myosins, with a large evolutionary distance ranging from insects (D. melanogaster) over invertebrates to humans (fig. 6). It is therefore possible to discuss the consequences of the R281T exchange by referring to crystal structures of orthologues of human MHC-beta, e.g. the S1 domain of chicken gizzard myosin (PDB entry 2MYS, approximately 75% sequence identity with S1 of human MHC-beta)[19]. In this structure, the position corresponding to human R281 (chicken R283) is involved in a salt bridge with a highly conserved aspartic acid residue (human D325/chicken D327) (fig. 5B). The salt bridge is buried below the protein surface and anchors an alpha-helix within a saddle-shaped structural protrusion on the surface of S1 (residues 275 to 330, approx.). Replacing either R281 or D325 will lead to the destabilization of this subregion within S1. Hence it is likely that a mutation of arginine 281 to threonine affects the normal folding and/or the ATPase activity of beta-myosin, leading to altered contractile function of the sarcomere.
###end p 37
###begin title 38
Localization of R281 in a protein model of the myosin heavy chain.
###end title 38
###begin p 39
###xml 399 403 399 403 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001362-Woo1">[33]</xref>
###xml 405 409 405 409 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001362-Villard1">[34]</xref>
###xml 99 106 <span type="species:ncbi:9031">chicken</span>
###xml 601 608 <span type="species:ncbi:9031">chicken</span>
A, Positions of amino acids affected in NVM, HCM and DCM. The mutations were plotted on a model of chicken skeletal myosin subfragment-1 (PDB code 2MYS). Functional sites are indicated by arrows. 68 selected mutations causing HCM are indicated by yellow spheres and 4 mutations causing DCM by green spheres. The mutations were selected from the UniProt database (UniProtKB) and from two publications[33], [34]. The described NVM causing mutation is highlighted as a blue sphere and labeled according to the position in MYH7_HUMAN. B, Close-up view of the salt bridge between residues R281 and D325 in chicken skeletal myosin subfragment-1 (PDB code 2MYS). The amino acids are numbered according to MYH7_HUMAN. The sulfate molecule (yellow and orange) marks the ATPase active site for better orientation. The residues R281 and D325 are shown according to the CPK color scheme (grey, carbon atoms; red, oxygen atoms, i.e. acidic side chain; light blue, nitrogen atoms, i.e. basic side chain). The salt bridge between R281 and D325 is symbolized by dashed black lines that indicate potential hydrogen bonds. The helix attached to D325 is highlighted in red.
###end p 39
###begin title 40
Multiple alignment of different myosin molecules.
###end title 40
###begin p 41
###xml 176 198 176 198 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Caenorhabditis elegans</italic>
###xml 810 832 810 832 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Caenorhabditis elegans</italic>
###xml 144 149 <span type="species:ncbi:9606">human</span>
###xml 151 160 <span type="species:ncbi:7227">fruit fly</span>
###xml 162 171 <span type="species:ncbi:7955">zebrafish</span>
###xml 176 198 <span type="species:ncbi:6239">Caenorhabditis elegans</span>
###xml 327 332 <span type="species:ncbi:9606">human</span>
###xml 393 398 <span type="species:ncbi:9606">human</span>
###xml 456 461 <span type="species:ncbi:9606">human</span>
###xml 517 523 <span type="species:ncbi:10090">murine</span>
###xml 581 587 <span type="species:ncbi:9986">rabbit</span>
###xml 646 653 <span type="species:ncbi:9031">chicken</span>
###xml 724 733 <span type="species:ncbi:7955">zebrafish</span>
###xml 761 770 <span type="species:ncbi:7227">fruit fly</span>
###xml 810 832 <span type="species:ncbi:6239">Caenorhabditis elegans</span>
The interacting sites R281 and D325 (both in bold, position numbering according to MYH7_HUMAN) are highly conserved between myosin molecules of human, fruit fly, zebrafish and Caenorhabditis elegans, respectively (*, identical position; :, conservative exchange). Sequence names correspond to SwissProt entry names: MYH7_HUMAN-human myosin heavy chain, cardiac muscle beta isoform; MYH1_HUMAN-human myosin heavy chain, skeletal muscle, adult 1; MYH4_HUMAN-human myosin heavy chain, skeletal muscle, fetal; MYH1_MOUSE-murine myosin heavy chain, skeletal muscle, adult 1; MYH4_RABIT-rabbit myosin heavy chain, skeletal muscle, juvenile; MYSS_CHICK-chicken myosin heavy chain, skeletal muscle, adult; Q802Z4_BRARE (Q802_BRARE)-zebrafish protein Q802Z4; MYSA_DROME-fruit fly myosin heavy chain, muscle; MYO3_CAEEL-Caenorhabditis elegans myosin heavy chain A.
###end p 41
###begin p 42
###xml 225 229 225 229 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYH7</italic>
###xml 510 517 510 517 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001362-g005">fig. 5A</xref>
###xml 519 523 519 523 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001362-Rayment2">[20]</xref>
We do not know at present why a mutation in a contractile protein can culminate in a similar condition like mutations that affect cytoskeletal components. Further, it remains unclear, why R281T-in contrast to all other known MYH7 mutations-causes NVM rather that HCM or DCM. Mutations associated with HCM and DCM are clustered in four functionally important regions: the actin-myosin interface, the ATPase active site with the ATP binding region, the essential light chain (ELC) binding interface and the rod (fig. 5A) [20]. In contrast to all other HCM or DCM mutations known so far, the R281T substitution is localized in exon 10. Hence, it will be interesting to see whether other mutations in the same exon cause a similar phenotype.
###end p 42
###begin title 43
Discussion
###end title 43
###begin p 44
In the present study, we have linked noncompaction of the ventricular myocardium to a mutation in the beta-myosin heavy chain gene. Despite the fact that a typical "HCM/DCM gene" was affected, none of the mutation carriers showed signs of canonical hypertrophic or dilated cardiomyopathy. Rather, some-but not all-mutation carriers had congenital heart disease, namely Ebstein's anomaly, i.e. a dislocation of the tricuspid valve, and/or an atrial septal defect. Thus, the R281T substitution was linked to either an isolated or non-isolated form of NVM that-in this family-did not develop into HCM or DCM.
###end p 44
###begin p 45
###xml 538 542 538 542 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYH7</italic>
###xml 1140 1144 1140 1144 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001362-Murphy1">[12]</xref>
The clinical consequences of the R281T mutation were diverse. Symptoms were generally absent in childhood and adolescence. One case of cardiac death in early childhood (III:1) may have been related to disease transmitted in this family, but no data exist. In two sisters of the third generation (III:4 and III:8) symptoms deterioated rapidly in the third and fourth decade of life, while one of their brothers (III:6) was at initial presentation asymptomatic, but he was identified as affected by noncompaction and also as carrier of the MYH7 mutation. (Note, this proband later declined follow-up investigations.) An older brother of the two affected sisters (III:2) died (in the 80s) from cardiac death at age 26. No clinical data as to details of his cardiac conditon are available, nor was he genotyped. It does not seem unlikely to us, however, that he was also a carrier of the mutation detected in his first-degree sibs. Noncompaction was in our family clearly identified in early childhood. The youngest NVM carrier was 7 years old at the time of diagnosis. Hence, in agreement with others we conclude that NVM was present at birth [12]. Otherwise, symptoms developed later in life, strongly suggesting an age-dependent penetrance of the condition in family DU-11.
###end p 45
###begin p 46
We hypothesize, that two nosological effects may be superimposed in the affected members of the family. One of them, noncompaction may have mild consequences, at least early in life. The second effect may result from the suggested structural change of the cardiac myosin heavy chain which possibly leads to an altered contractile function causing phenotypic consequences later in life. If a myosin-related dysfunction was involved, it did, however, not induce myocardial hypertrophy or chamber dilatation, the structural hallmarks of HCM and DCM, respectively. Congenital malformations such as Ebstein's anomaly or atrial septal defect, as seen in some family members, may have further contributed to the symptoms.
###end p 46
###begin p 47
###xml 445 449 442 446 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYH6</italic>
###xml 660 664 649 653 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYH6</italic>
###xml 705 709 694 698 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYH6</italic>
###xml 826 830 811 815 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001362-Ching1">[21]</xref>
###xml 931 935 913 917 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001362-Reiser2">[22]</xref>
###xml 993 997 975 979 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYH7</italic>
###xml 1105 1109 1087 1091 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYH3</italic>
###xml 1594 1598 1576 1580 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001362-Toydemir1">[23]</xref>
###xml 1631 1636 1613 1618 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYH11</italic>
###xml 1973 1977 1955 1959 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001362-Zhu1">[24]</xref>
###xml 406 412 <span type="species:ncbi:9606">humans</span>
###xml 616 623 <span type="species:ncbi:9031">chicken</span>
A key question is whether a mutation in a contractile protein (such as the beta-myosin heavy chain) can trigger defects in both compaction of the myocardium and septation of the atria. In this context it is noteworthy that our results are essentially in line with three recent reports demonstrating, that mutations in myosin heavy chain genes can have damaging effects on the cardiovascular development in humans. A missense mutation, I820N, in MYH6, which codes for predominantly atrial alpha-myosin heavy chain (MHC-alpha) results in incomplete atrial septum formation. A similar effect was observed in developing chicken atria upon knock-down repression of MYH6 using oligonucleotides complementary to MYH6 mRNA, suggesting that an altered MHC-alpha structure or lack of this protein contribute to congenital heart disease [21]. Since the beta-isoform of myosin heavy chain is also present in atria, albeit at rather low levels [22], one has to consider the possibility, that a mutation in MYH7 can also provide the basis for the development of ASD. Secondly, in a separate study, various mutations in MYH3 [MIM 160720] encoding embryonic myosin heavy chain have been causally linked to the occurence of the Freeman-Sheldon syndrome [MIM 193700] and the Sheldon-Hall syndrome (alternatively designated type 2B distal arthrogryposis [MIM 601680]). These syndromes are characterized by congenital manifestation of severe isolated or multiple contractures. It was proposed, that dysfunctional force production in myofibers in an early stage of embryogenesis was responsible for these symdromes [23]. In a third study, mutations in MYH11 [MIM 160745], the gene coding for smooth muscle (SM) myosin heavy chain were shown to trigger patent ductus arteriosus as a congenital trait and the formation of thoracic aortic aneurysms or aortic dissections in adults. A dominant negative effect was strongly suggested to be due to improper coiled-coil formation of the SM myosin rod [24]. Taken together, these data argue in favor of a general role of the myosin heavy chain in the development of the cardiovascular system.
###end p 47
###begin p 48
In conclusion, our data suggest that a mutation in the beta-myosin heavy chain causes noncompaction of the ventricular myocardium associated with a variable expressivity of the disease. The combination of an 'old' gene with a 'new' phenotype may help to unravel causes, mechanisms and clinical implications of NVM.
###end p 48
###begin title 49
Note added in proof
###end title 49
###begin p 50
In the course of the review process, three different manuscripts have been published that link defects in sarcomeric proteins to noncompaction of the ventricular myocardium (Monserrat et al., European Heart Journal, 2007; Hoedemaekers et al., European Heart Journal, 2007; Kaneda et al., Clinical Science, 2007). However, the present work is the only one that shows linkage of the disease gene region to noncompaction in a genome-wide analysis.
###end p 50
###begin title 51
Materials and Methods
###end title 51
###begin title 52
Clinical evaluation
###end title 52
###begin p 53
###xml 634 638 634 638 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001362-Murphy1">[12]</xref>
###xml 640 644 640 644 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001362-Jenni1">[25]</xref>
###xml 1506 1513 1504 1511 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s2">Results</xref>
###xml 1829 1830 1825 1826 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 1849 1853 1845 1849 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001362-Edwards1">[26]</xref>
###xml 225 237 <span type="species:ncbi:9606">participants</span>
###xml 1438 1446 <span type="species:ncbi:9606">patients</span>
The clinical and genetic studies were carried out according to institutional guidelines after approval of the local ethics committee (Ethics Committee of the University of Witten/Herdecke) and given informed consent from all participants. Twenty four members of family DU-11 were clinically evaluated by a review of their medical history, physical examination, 12-lead echocardiography (ECG) and 2-dimensional transthoracic echocardiography (TTE). Echocardiographic measurements of wall thickness and cavity dimensions were performed using M-mode and 2-dimensional views. NVM was identified based on the following diagnostic criteria [12], [25]: Presence of prominent multiple trabeculations, deep recesses in the thickened myocardium filled with blood from the ventricular cavity (as visualized by color Doppler imaging), presence of a two layered structure of the endomyocardium with a thin compacted layer and a thick non-compacted layer. The NVM affection status was classified as follows: unknown, deceased individuals and/or no clinical records available; unaffected, absence of a non-compacted myocardial layer; partially affected, documented apical thickening (<18 mm) due to noncompaction with a ratio of non-compacted/compacted myocardium (N/C ratio) of either <2 or not quantifiable; affected, apical thickening (>18 mm) due to noncompaction with a N/C ratio >/=2. We note, that neither the partially affected nor the affected patients showed signs of canonical hypertrophic cardiomyopathy (see Results section). The NVM status of individual III:8 was confirmed by magnetic resonance tomography (MRT). Ebstein's anomaly was diagnosed echocardiographically based on the dislocation of the septal leaflet of the tricuspid valve from the insertion of the anterior leaflet of the mitral valve towards the apex by >/=8 mm/m2 body surface area [26]. EDTA-blood was taken from 24 members of family DU-11, and DNA was available from 184 healthy volunteers.
###end p 53
###begin title 54
Linkage analysis and sequencing
###end title 54
###begin p 55
###xml 292 296 292 296 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYH7</italic>
###xml 331 336 331 336 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYO I</italic>
###xml 360 365 360 365 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYOII</italic>
###xml 372 376 372 376 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001362-Polymeropoulos1">[27]</xref>
###xml 378 382 378 382 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001362-Schwartz1">[28]</xref>
###xml 790 794 790 794 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001362-Lindner1">[29]</xref>
###xml 1183 1187 1183 1187 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001362-Sobel1">[30]</xref>
###xml 1270 1274 1270 1274 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYH6</italic>
###xml 1279 1283 1279 1283 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYH7</italic>
###xml 1426 1430 1426 1430 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001362-Jaenicke1">[31]</xref>
###xml 1819 1823 1819 1823 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYH7</italic>
###xml 1999 2003 1999 2003 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYH7</italic>
###xml 2066 2070 2066 2070 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001362-Waldmuller1">[32]</xref>
###xml 1258 1263 <span type="species:ncbi:9606">human</span>
###xml 1314 1321 <span type="species:ncbi:9606">patient</span>
DNA was extracted from peripheral blood samples using standard methods. A genome-wide scan with a set of 430 polymorphic microsatellite markers (modified Weber9-set, Marshfield Institute), average spacing of about 10 cM, was performed. Additional markers including two microsatellites in the MYH7 gene (one in the promotor region, MYO I, and one in intron 24, MYOII (ref. [27], [28]) , were used for fine mapping. Products of PCR assays with fluorescently labeled primers were analyzed by automated capillary genotyping on a MegaBACE 1000 (GE Healthcare Biosciences, Piscataway, NJ) and scored using the Genetic Profiler analysis software (GE Healthcare Biosciences, Piscataway, NJ). A two-point linkage analysis was performed using the program SuperLink of easyLINKAGE Plus (version 5.02) [29] assuming an autosomal dominant model of disease inheritance with a disease allele frequency of 0.001, equal female and male recombination rates and two liability classes. The penetrance values were set at 0.9, 0.8 or 0.7 for the affecteds (liability class 1) and at 0.5 for the partially affected (II:3 and IV:6), respectively. Haplotypes were reconstructed using SIMWALK2 (version 2.91) [30]. Bidirectional sequencing of all coding exons and splice sites of the human genes MYH6 and MYH7 was carried out for the index patient III:4 of family DU-11. The primer sequences were obtained on the basis of reported nucleotide sequences [31] and the Genbank entry NT_026437. Sequencing was performed according to the Dye Terminator Cycle Sequencing Quick Start Kit protocol (Beckman Coulter, Fullerton, CA) on a CEQ 8000 XL DNA Sequencing System (Beckman Coulter, Fullerton, CA). Sequences were analyzed and aligned using the CEQuence Investigator program (Beckman Coulter, Fullerton, CA). In the other members of the family only MYH7 exon 10 was sequenced to determine the occurrence of the R281T mutation. Healthy controls were analyzed by pyrosequencing for the presence or absence of the R281T mutation in MYH7 exon 10. Pyrosequencing was performed as described previously [32].
###end p 55
###begin title 56
Protein modeling
###end title 56
###begin p 57
Protein models were derived from the RCSB Protein Data Bank (see below). The ribbon plots were drawn using the program ViewerPro version 4.2 (Accelrys Inc., San Diego, CA) and PyMOL Molecular Graphics System (Delano Scientific, San Carlos, CA).
###end p 57
###begin title 58
Protein alignment and accession numbers
###end title 58
###begin p 59
Multiple sequence alignments were performed with the ClustalW program.
###end p 59
###begin p 60
###xml 9 21 9 21 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Homo sapiens</italic>
###xml 72 76 72 76 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYH6</italic>
###xml 81 85 81 85 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYH7</italic>
###xml 99 111 99 111 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Homo sapiens</italic>
###xml 846 868 846 868 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Caenorhabditis elegans</italic>
###xml 9 21 <span type="species:ncbi:9606">Homo sapiens</span>
###xml 99 111 <span type="species:ncbi:9606">Homo sapiens</span>
###xml 203 210 <span type="species:ncbi:9031">chicken</span>
###xml 266 271 <span type="species:ncbi:9606">human</span>
###xml 363 368 <span type="species:ncbi:9606">human</span>
###xml 429 434 <span type="species:ncbi:9606">human</span>
###xml 492 497 <span type="species:ncbi:9606">human</span>
###xml 553 559 <span type="species:ncbi:10090">murine</span>
###xml 617 623 <span type="species:ncbi:9986">rabbit</span>
###xml 682 689 <span type="species:ncbi:9031">chicken</span>
###xml 760 769 <span type="species:ncbi:7955">zebrafish</span>
###xml 797 806 <span type="species:ncbi:7227">fruit fly</span>
###xml 846 868 <span type="species:ncbi:6239">Caenorhabditis elegans</span>
Genbank: Homo sapiens chromosome 14 genomic contig, reference assembly (MYH6 and MYH7), NT_026437; Homo sapiens heavy polypeptide 7, cardiac muscle, beta (MYH7), NM_000257; RCSB Protein Data Bank (PDB): chicken skeletal muscle myosin subfragment-1, 2MYS; UniProtKB: human myosin heavy chain, cardiac muscle beta isoform, P12883; SwissProt entry names: MYH7_HUMAN-human myosin heavy chain, cardiac muscle beta isoform; MYH1_HUMAN-human myosin heavy chain, skeletal muscle, adult 1; MYH4_HUMAN-human myosin heavy chain, skeletal muscle, fetal; MYH1_MOUSE-murine myosin heavy chain, skeletal muscle, adult 1; MYH4_RABIT-rabbit myosin heavy chain, skeletal muscle, juvenile; MYSS_CHICK-chicken myosin heavy chain, skeletal muscle, adult; Q802Z4_BRARE (Q802_BRARE)-zebrafish protein Q802Z4; MYSA_DROME-fruit fly myosin heavy chain, muscle; MYO3_CAEEL-Caenorhabditis elegans myosin heavy chain A.
###end p 60
###begin title 61
Web Resources
###end title 61
###begin p 62
URLs for data presented herein are as follows:
###end p 62
###begin p 63
GenBank,
###end p 63
###begin p 64
RCSB Protein Data Bank,
###end p 64
###begin p 65
UniProtKB/Swiss-Prot DATABASE,
###end p 65
###begin p 66
OMIM,
###end p 66
###begin p 67
We are particularly grateful to all family members who participated in this study. We thank Joanne Davies for critical reading of the manuscript and the reviewers for providing constructive suggestions.
###end p 67
###begin title 68
References
###end title 68
###begin article-title 69
Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of cardiomyopathies.
###end article-title 69
###begin article-title 70
Contemporary definitions and classification of the cardiomyopathies: an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention.
###end article-title 70
###begin article-title 71
Genetic basis of hypertrophic cardiomyopathy.
###end article-title 71
###begin article-title 72
Genetics of dilated cardiomyopathy.
###end article-title 72
###begin article-title 73
Genetics of right ventricular cardiomyopathy.
###end article-title 73
###begin article-title 74
Identification of a rare congenital anomaly of the myocardium by two-dimensional echocardiography: persistence of isolated myocardial sinusoids.
###end article-title 74
###begin article-title 75
Isolated noncompaction of left ventricular myocardium. A study of eight cases.
###end article-title 75
###begin article-title 76
Clinical features of isolated noncompaction of the ventricular myocardium: long-term clinical course, hemodynamic properties, and genetic background.
###end article-title 76
###begin article-title 77
Neonatal, lethal noncompaction of the left ventricular myocardium is allelic with Barth syndrome.
###end article-title 77
###begin article-title 78
###xml 24 32 <span type="species:ncbi:9606">patients</span>
Novel gene mutations in patients with left ventricular noncompaction or Barth syndrome.
###end article-title 78
###begin article-title 79
Isolated left ventricular noncompaction: an unclassified cardiomyopathy with severe prognosis in adults.
###end article-title 79
###begin article-title 80
Natural history and familial characteristics of isolated left ventricular non-compaction.
###end article-title 80
###begin article-title 81
Developmental patterning of the myocardium.
###end article-title 81
###begin article-title 82
###xml 28 36 <span type="species:ncbi:9606">patients</span>
Mutations in Cypher/ZASP in patients with dilated cardiomyopathy and left ventricular non-compaction.
###end article-title 82
###begin article-title 83
Ventricular noncompaction and distal chromosome 5q deletion.
###end article-title 83
###begin article-title 84
Novel gene locus for autosomal dominant left ventricular noncompaction maps to chromosome 11p15.
###end article-title 84
###begin article-title 85
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human cardiac myosin heavy chain isoforms in fetal and failing adult atria and ventricles.
###end article-title 85
###begin article-title 86
###xml 42 47 <span type="species:ncbi:9606">human</span>
###xml 191 196 <span type="species:ncbi:9606">human</span>
Molecular cloning and characterization of human cardiac alpha- and beta-form myosin heavy chain complementary DNA clones. Regulation of expression during development and pressure overload in human atrium.
###end article-title 86
###begin article-title 87
Three-dimensional structure of myosin subfragment-1: a molecular motor.
###end article-title 87
###begin article-title 88
Structural interpretation of the mutations in the beta-cardiac myosin that have been implicated in familial hypertrophic cardiomyopathy.
###end article-title 88
###begin article-title 89
Mutation in myosin heavy chain 6 causes atrial septal defect.
###end article-title 89
###begin article-title 90
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human cardiac myosin heavy chain isoforms in fetal and failing adult atria and ventricles.
###end article-title 90
###begin article-title 91
Mutations in embryonic myosin heavy chain (MYH3) cause Freeman-Sheldon syndrome and Sheldon-Hall syndrome.
###end article-title 91
###begin article-title 92
Mutations in myosin heavy chain 11 cause a syndrome associating thoracic aortic aneurysm/aortic dissection and patent ductus arteriosus.
###end article-title 92
###begin article-title 93
Echocardiographic and pathoanatomical characteristics of isolated left ventricular non-compaction: a step towards classification as a distinct cardiomyopathy.
###end article-title 93
###begin article-title 94
Embryology and pathologic features of Ebstein's anomaly.
###end article-title 94
###begin article-title 95
###xml 40 45 <span type="species:ncbi:9606">human</span>
Dinucleotide repeat polymorphism at the human cardiac beta-myosin gene.
###end article-title 95
###begin article-title 96
Exclusion of cardiac myosin heavy chain and actin gene involvement in hypertrophic cardiomyopathy of several French families.
###end article-title 96
###begin article-title 97
easyLINKAGE: a PERL script for easy and automated two-/multi-point linkage analyses.
###end article-title 97
###begin article-title 98
Descent graphs in pedigree analysis: applications to haplotyping, location scores, and marker-sharing statistics.
###end article-title 98
###begin article-title 99
###xml 29 34 <span type="species:ncbi:9606">human</span>
The complete sequence of the human beta-myosin heavy chain gene and a comparative analysis of its product.
###end article-title 99
###begin article-title 100
Novel deletions in MYH7 and MYBPC3 identified in Indian families with familial hypertrophic cardiomyopathy.
###end article-title 100
###begin article-title 101
Mutations of the beta myosin heavy chain gene in hypertrophic cardiomyopathy: critical functional sites determine prognosis.
###end article-title 101
###begin article-title 102
Mutation screening in dilated cardiomyopathy: prominent role of the beta myosin heavy chain gene.
###end article-title 102
###begin p 103
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 103
###begin p 104
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: This study was supported by the German Federal Ministry of Science and Education (BMBF) through the National Genome Research Network (grant 01GR0416 to P.N.) and through the Competence Network of Heart Failure, FKZ 01GI0205.
###end p 104

